Access the full text.
Sign up today, get DeepDyve free for 14 days.
Emmanuelle Vidal-Petiot, Ian Ford, N. Greenlaw (2017)
Cardiovascular Event Rates and Mortality According to Achieved Systolic and Diastolic Blood Pressure in Patients With Stable Coronary Artery Disease: An International Cohort StudyJournal of Vascular Surgery, 65
(2001)
Cardiovascular Physiology. 8th ed
J. Hay (1931)
A British Medical Association Lecture on THE SIGNIFICANCE OF A RAISED BLOOD PRESSURE *British Medical Journal, 2
M. Böhm, H. Schumacher, K. Teo, E. Lonn, F. Mahfoud, JohannesF. Mann, G. Mancia, J. Redón, R. Schmieder, K. Sliwa, M. Weber, B. Williams, S. Yusuf (2017)
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trialsThe Lancet, 389
E. Lonn, J. Bosch, P. López-Jaramillo, Jun Zhu, Li-sheng Liu, P. Pais, R. Diaz, D. Xavier, K. Sliwa, A. Dans, Á. Avezum, L. Piegas, K. Keltai, M. Keltai, Irina Chazova, R. Peters, C. Held, K. Yusoff, B. Lewis, P. Janský, A. Parkhomenko, K. Khunti, W. Toff, C. Reid, J. Varigos, Lawrence Leiter, D. Molina, R. McKelvie, J. Pogue, J. Wilkinson, Hyejung Jung, G. Dagenais, S. Yusuf (2016)
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.The New England journal of medicine, 374 21
F. Messerli, G. Mancia, C. Conti, Ann Hewkin, S. Kupfer, Annette Champion, R. Kolloch, A. Bénétos, C. Pepine (2006)
Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?Annals of Internal Medicine, 144
Rydén (2013)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)Eur Heart J, 34
James (2014)
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)Jama, 311
S. Durrleman, R. Simon (1989)
Flexible regression models with cubic splines.Statistics in medicine, 8 5
P. Kearney, Megan Whelton, K. Reynolds, P. Muntner, P. Whelton, Jiang He (2005)
Global burden of hypertension: analysis of worldwide dataThe Lancet, 365
(2016)
Diastolic blood pressure, subclinical myocardial damage, and cardiac events: implications for blood pressure control
G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cífková, G. Backer, A. Dominiczak, M. Galderisi, D. Grobbee, T. Jaarsma, P. Kirchhof, S. Kjeldsen, S. Laurent, A. Manolis, P. Nilsson, L. Ruilope, R. Schmieder, P. Sirnes, P. Sleight, M. Viigimaa, B. Waeber, F. Zannad (2007)
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).Journal of hypertension, 31 7
Mancia (2013)
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Eur Heart J, 34
J Blacher, JA Staessen, X Girerd, J Gasowski, L Thijs, L Liu, JG Wang, RH Fagard, ME. Safar (2000)
Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patientsArch Intern Med, 160
R. Cooper-DeHoff, Y. Gong, E. Handberg, A. Bavry, S. Denardo, G. Bakris, C. Pepine (2010)
Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.JAMA, 304 1
R. Rosenman, R. Sholtz, R. Brand (1976)
A Study of Comparative Blood Pressure Measures in Predicting Risk of Coronary Heart DiseaseCirculation, 54
Gabriel Tajeu, John Booth, Lisandro Colantonio, R. Gottesman, G. Howard, D. Lackland, Emily O'Brien, S. Oparil, J. Ravenell, M. Safford, S. Seals, D. Shimbo, S. Shea, T. Spruill, R. Tanner, P. Muntner (2017)
Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm HgCirculation, 136
J. Blacher, J. Staessen, X. Girerd, J. Gąsowski, L. Thijs, Li-sheng Liu, J. Wang, R. Fagard, M. Safar (2000)
Pulse Pressure Not Mean Pressure Determines Cardiovascular Risk in Older Hypertensive PatientsJAMA Internal Medicine, 160
Vidal-Petiot (2016)
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort studyLancet
F. Messerli, G. Panjrath (2009)
The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?Journal of the American College of Cardiology, 54 20
P. Grant, F. Cosentino (2019)
The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.European heart journal, 40 39
B. Bergmark, B. Scirica, P. Steg, Christina Fanola, Yared Gurmu, Ofri Mosenzon, Avivit Cahn, I. Raz, Deepak Bhatt (2018)
Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular riskEuropean Heart Journal, 39
W. Kannel, T. Gordon, M. Schwartz (1971)
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study.The American journal of cardiology, 27 4
P. James, S. Oparil, B. Carter, W. Cushman, C. Dennison-Himmelfarb, J. Handler, D. Lackland, M. LeFevre, T. Mackenzie, O. Ogedegbe, Sidney Smith, L. Svetkey, S. Taler, R. Townsend, J. Wright, A. Narva, E. Ortiz (2012)
Evidence-Based Guideline for the Management of High Blood Pressure in AdultsJAMA, 1097
E. Rapsomaniki, A. Timmis, J. George, M. Pujades-Rodriguez, A. Shah, Spiros Denaxas, I. White, M. Caulfield, J. Deanfield, L. Smeeth, B. Williams, A. Hingorani, H. Hemingway (2014)
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million peopleLancet, 383
S. Yusuf, K. Teo, C. Anderson, J. Pogue, L. Dyal, I. Copland, H. Schumacher, Dagenais Gr, P. Sleight (2008)
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trialThe Lancet, 372
T. Weber, J. Auer, M. O'Rourke, E. Kvas, E. Lassnig, R. Berent, B. Eber (2004)
Arterial Stiffness, Wave Reflections, and the Risk of Coronary Artery DiseaseCirculation: Journal of the American Heart Association, 109
H. Rosolová, T. Pelikanova, Z. Motovska (2014)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with EASD. Summary of the document prepared by the Czech Society of CardiologyCor et vasa, 56
M. Naghavi, Haidong Wang, R. Lozano, A. Davis, Xiaofeng Liang, Maigeng Zhou, S. Vollset, A. Ozgoren, S. Abdalla, F. Abd-Allah, M. Aziz, S. Abera, V. Aboyans, Biju Abraham, J. Abraham, K. Abuabara, I. Abubakar, L. Abu-Raddad, N. Abu-Rmeileh, T. Achoki, A. Adelekan, Z. Ademi, K. Adofo, A. Adou, J. Adsuar, J. Ärnlöv, E. Agardh, D. Akena, M. Khabouri, D. Alasfoor, Mohammed Albittar, M. Alegretti, A. Aleman, Z. Alemu, R. Alfonso-Cristancho, Samia Alhabib, Mohammed Ali, R. Ali, F. Alla, F. Lami, P. Allebeck, Mohammad Almazroa, R. Salman, U. Alsharif, E. Álvarez, Nelson Alviz-Guzman, A. Amankwaa, A. Amare, O. Ameli, Hassan Amini, W. Ammar, H. Anderson, B. Anderson, C. Antonio, P. Anwari, Henry Apfel, S. Cunningham, V. Arsenijevic, A. Artaman, Majed Asad, R. Asghar, Reza Assadi, Lydia Atkins, C. Atkinson, A. Badawi, M. Bahit, Talal Bakfalouni, K. Balakrishnan, Shivanthi Balalla, A. Banerjee, Ryan Barber, S. Barker-Collo, S. Barquera, L. Barregard, L. Barrero, T. Barrientos-Gutiérrez, Arindam Basu, S. Basu, M. Basulaiman, J. Beardsley, Neeraj Bedi, E. Beghi, T. Bekele, M. Bell, C. Benjet, D. Bennett, I. Benseñor, H. Benzian, A. Bertozzi-Villa, T. Beyene, N. Bhala, A. Bhalla, Z. Bhutta, B. Bikbov, A. Abdulhak, S. Biryukov, J. Blore, F. Blyth, M. Bohensky, G. Borges, D. Bose, S. Boufous, R. Bourne, L. Boyers, M. Brainin, M. Brauer, C. Brayne, A. Brazinova, N. Breitborde, H. Brenner, A. Briggs, Jonathan Brown, T. Brugha, G. Buckle, L. Bui, G. Bukhman, M. Burch, Ismael Nonato, H. Carabin, Rosario Cárdenas, J. Carapetis, D. Carpenter, V. Caso, Carlos Castanda-Orjuela, R. Castro, F. Catalá-López, F. Cavalleri, Jung-Chen Chang, Fiona Charlson, Xuan Che, Honglei Chen, Yingyao Chen, J. Chen, Zhengming Chen, P. Chiang, Odgerel Chimed-Ochir, Rajiv Chowdhury, H. Christensen, C. Christophi, Ting-Wu Chuang, S. Chugh, M. Cirillo, M. Coates, L. Coffeng, M. Coggeshall, A. Cohen, V. Colistro, Samantha Colquhoun, Mercedes Colomar, L. Cooper, C. Cooper, Luis Coppola, Monica Cortinovis, K. Courville, B. Cowie, M. Criqui, J. Crump, L. Cuevas-Nasu, I. Leite, Kaustubh Dabhadkar, L. Dandona, R. Dandona, E. Dansereau, P. Dargan, A. Dayama, V. Cruz-Góngora, S. Vega, D. Leo, L. Degenhardt, B. Pozo-Cruz, R. Dellavalle, Kebede Deribe, D. Jarlais, Muluken Dessalegn, G. deVeber, S. Dharmaratne, M. Dherani, J. Díaz-Ortega, C. Díaz-Torné, D. Dicker, E. Ding, K. Dokova, E. Dorsey, T. Driscoll, L. Duan, H. Duber, Adnan Durrani, B. Ebel, K. Edmond, R. Ellenbogen, Yousef Elshrek, S. Ermakov, H. Erskine, B. Eshrati, A. Esteghamati, Kara Estep, Thomas Fürst, S. Fahimi, A. Fahrion, E. Faraon, F. Farzadfar, Derek Fay, A. Feigl, V. Feigin, M. Felicio, S. Fereshtehnejad, J. Fernandes, A. Ferrari, T. Fleming, N. Foigt, Kyle Foreman, M. Forouzanfar, F. Fowkes, U. Paleo, R. Franklin, N. Futran, L. Gaffikin, K. Gambashidze, F. Gankpé, Francisco Garc-Guerra, A. Garcia, J. Geleijnse, B. Gessner, K. Gibney, R. Gillum, S. Gilmour, I. Ginawi, M. Giroud, E. Glaser, S. Goenka, H. Dantés, P. Gona, D. González-Medina, C. Guinovart, Rahul Gupta, Rajeev Gupta, R. Gosselin, C. Gotay, A. Goto, H. Gouda, Nicholas Graetz, K. Greenwell, H. Gugnani, D. Gunnell, Reyna Gutiiérez, J. Haagsma, N. Hafezi-Nejad, H. Hagan, M. Hagströmer, Y. Halasa, R. Hamadeh, Hannah Hamavid, M. Hammami, Jamie Hancock, G. Hankey, Gillian Hansen, H. Harb, H. Harewood, J. Haro, Rasmus Havmoeller, R. Hay, S. Hay, M. Hedayati, I. Pi, K. Heuton, P. Heydarpour, Hideki Higashi, M. Híjar, H. Hoek, H. Hoffman, J. Hornberger, H. Hosgood, Mazeda Hossain, P. Hotez, D. Hoy, M. Hsairi, G. Hu, John Huang, Mark Huffman, Andrew Hughes, A. Husseini, Chantal Huynh, Marissa Iannarone, K. Iburg, B. Idrisov, Nayu Ikeda, K. Innos, M. Inoue, F. Islami, S. Ismayilova, K. Jacobsen, S. Jassal, S. Jayaraman, P. Jensen, V. Jha, G. Jiang, Ying Jiang, J. Jonas, Jonathan Joseph, K. Juel, E. Kabagambe, H. Kan, A. Karch, C. Karimkhani, G. Karthikeyan, N. Kassebaum, Anil Kaul, N. Kawakami, Konstantin Kazanjan, Dhruv Kazi, A. Kemp, A. Kengne, A. Keren, M. Kereselidze, Y. Khader, S. Khalifa, E. Khan, G. Khan, Y. Khang, C. Kieling, Y. Kinfu, J. Kinge, Daniel Kim, Sungroul Kim, M. Kivipelto, L. Knibbs, A. Knudsen, Y. Kokubo, S. Kosen, Meera Kotagal, M. Kravchenko, S. Krishnaswami, H. Krueger, B. Defo, E. Kuipers, B. Bicer, Chanda Kulkarni, Veena Kulkarni, Kaushalendra Kumar, Ravindra Kumar, G. Kwan, H. Kyu, T. Lai, A. Balaji, R. Lalloo, T. Lallukka, H. Lam, Q. Lan, V. Lansingh, H. Larson, A. Larsson, P. Lavados, A. Lawrynowicz, J. Leasher, Jong-Tae Lee, J. Leigh, M. Leinsalu, R. Leung, Carly Levitz, Bin Li, Yichong Li, Yongmei Li, Chelsea Liddell, Stephen Lim, G. Lima, M. Lind, S. Lipshultz, Shiwei Liu, Yang Liu, B. Lloyd, K. Lofgren, G. Logroscino, S. London, J. Lortet-Tieulent, P. Lotufo, R. Lucas, R. Lunevicius, R. Lyons, Stefan Ma, V. Machado, Michael MacIntyre, M. Mackay, J. MacLachlan, C. Magis-Rodríguez, A. Mahdi, M. Majdan, R. Malekzadeh, S. Mangalam, C. Mapoma, M. Marape, W. Marcenes, Christopher Margono, G. Marks, M. Marzan, J. Masci, M. Mashal, F. Masiye, A. Mason-Jones, R. Matzopolous, B. Mayosi, Tasara Mazorodze, J. Mcgrath, A. Mckay, M. Mckee, Abigail Mclain, P. Meaney, M. Mehndiratta, Fabiola Mejía-Rodríguez, Y. Melaku, M. Meltzer, Z. Memish, W. Mendoza, G. Mensah, A. Meretoja, F. Mhimbira, T. Miller, E. Mills, A. Misganaw, S. Mishra, C. Mock, T. Moffitt, N. Ibrahim, K. Mohammad, A. Mokdad, G. Mola, L. Monasta, J. Monis, J. Hernandez, M. Montico, T. Montine, M. Mooney, A. Moore, M. Moradi-Lakeh, Andrew Moran, R. Mori, J. Moschandreas, W. Moturi, Madeline Moyer, D. Mozaffarian, U. Mueller, Mitsuru Mukaigawara, Erin Mullany, Joseph Murray, A. Mustapha, Paria Naghavi, A. Naheed, K. Naidoo, L. Naldi, D. Nand, V. Nangia, K. Narayan, D. Nash, Jamal Nasher, C. Nejjari, R. Nelson, M. Neuhouser, S. Neupane, P. Newcomb, L. Newman, C. Newton, Marie Ng, F. Ngalesoni, Grant Nguyen, Nhung Nguyen, M. Nisar, S. Nolte, O. Norheim, R. Norman, B. Norrving, L. Nyakarahuka, Shaun Odell, M. O’Donnell, T. Ohkubo, Summer Ohno, B. Olusanya, S. Omer, John Opio, O. Orisakwe, K. Ortblad, Alberto Ortiz, M. Otayza, A. Pain, J. Pandian, C. Panelo, Jeemon Panniyammakal, C. Papachristou, A. Caicedo, S. Patten, G. Patton, V. Paul, B. Pavlin, N. Pearce, C. Pellegrini, David Pereira, Sophie Peresson, R. Perez-Padilla, F. Pérez-Ruiz, N. Perico, A. Pervaiz, K. Pesudovs (2015)
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 385
S. Yusuf, K. Teo, J. Pogue, L. Dyal, I. Copland, H. Schumacher, G. Dagenais, P. Sleight, C. Anderson (2008)
Telmisartan, ramipril, or both in patients at high risk for vascular events.The New England journal of medicine, 358 15
A. Protogerou, J. Blacher, M. Safar (2013)
Isolated systolic hypertension: ‘to treat or not to treat’ and the role of central haemodynamicsJournal of Hypertension, 31
W. Cushman, Gregory Evans, R. Byington, David Goff, Richard Grimm, Jeffrey Cutler, D. Simons-Morton, J. Basile, Marshall Corson, J. Probstfield, Lois Katz, K. Peterson, W. Friedewald, John Buse, J. Bigger, H. Gerstein, Faramarz Ismail-Beigi (2010)
Effects of intensive blood-pressure control in type 2 diabetes mellitus.The New England journal of medicine, 362 17
G. Mancia, G. Grassi (2014)
Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Pro Side of the ArgumentHypertension, 63
D. Herrington, W. Brown, L. Mosca, Warren Davis, Barry Eggleston, W. Hundley, J. Raines (2004)
Relationship Between Arterial Stiffness and Subclinical Aortic AtherosclerosisCirculation, 110
W. Ambrosius, K. Sink, C. Foy, D. Berlowitz, A. Cheung, W. Cushman, Lawrence Fine, D. Goff, K. Johnson, A. Killeen, C. Lewis, S. Oparil, D. Reboussin, M. Rocco, Joni Snyder, J. Williamson, J. Wright, P. Whelton (2014)
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT)Clinical Trials, 11
G. Mancia, R. Fagard, K. Narkiewicz, J. Redón, A. Zanchetti, M. Böhm, T. Christiaens, R. Cífková, G. Backer, A. Dominiczak, M. Galderisi, D. Grobbee, T. Jaarsma, P. Kirchhof, S. Kjeldsen, S. Laurent, A. Manolis, P. Nilsson, L. Ruilope, R. Schmieder, P. Sirnes, P. Sleight, M. Viigimaa, B. Waeber, F. Zannad, M. Burnier, E. Ambrosioni, M. Caufield, A. Coca, M. Olsen, C. Tsioufis, P. Borne, J. Zamorano, S. Achenbach, H. Baumgartner, Jeroen Bax, H. Bueno, V. Dean, C. Deaton, Ç. Erol, R. Ferrari, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, P. Lancellotti, A. Linhart, P. Nihoyannopoulos, M. Piepoli, P. Ponikowski, J. Tamargo, M. Tendera, A. Torbicki, W. Wijns, S. Windecker, D. Clement, T. Gillebert, E. Rosei, S. Anker, J. Bauersachs, J. Hitij, M. Buyzere, S. Geest, G. Derumeaux, S. Erdine, C. Farsang, C. Funck-Brentano, V. Gerc, G. Germano, S. Gielen, H. Haller, J. Jordan, T. Kahan, M. Komajda, D. Lovic, H. Mahrholdt, J. Östergren, G. Parati, J. Perk, J. Polónia, B. Popescu, Ž. Reiner, L. Rydén, Y. Sirenko, A. Stanton, H. Struijker-Boudier, C. Vlachopoulos, M. Volpe, D. Wood (2013)
The 2013 ESH/ESC guidelines for the management of arterial hypertensionEuropean Heart Journal, 34
E. Casiglia, V. Tikhonoff, A. Mazza, A. Piccoli, A. Pessina (2002)
Pulse pressure and coronary mortality in elderly men and women from general populationJournal of Human Hypertension, 16
AimsCurrent guidelines of hypertensive management recommend upper limits for systolic (SBP) and diastolic blood pressure (DBP). J-curve associations of BP with risk exist for some outcomes suggesting that lower limits of DBP goals may also apply. We examined the association between mean attained DBP and cardiovascular (CV) outcomes in patients who achieved an on-treatment SBP in the range of 120 to <140 mmHg in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET) and Telmisartan Randomized AssessmeNt Study in ACE iNtolerant participants with cardiovascular Disease (TRANSCEND) trials on patients with high CV risk. This SBP range was associated with the lowest CV risk.MethodsWe analysed the outcome data from patients age 55 years or older with CV disease from the ONTARGET and TRANSCEND trials that randomized high-risk patients to ramipril, telmisartan, and the combination. In patients with controlled SBP (on-treatment 120 to <140 mmHg), the composite outcome of CV death, myocardial infarction, stroke and hospital admission for heart failure, the components thereof, and all-cause mortality were analysed according to mean on-treatment DBP as categorical (<70, 70 to <80, 80 to <90, and ≥90 mmHg) and continuous variable as well as the change of DBP according to baseline DBP. Pulse pressure (PP) was related to outcomes as a continuous variable.ResultsIn 16 099 of 31 546 patients, mean achieved SBP was 120 to <140 mmHg. The nominally lowest risk for all outcomes was observed at an achieved DBP of 70 to <80 mmHg. A higher achieved DBP was associated with a higher risk for the outcomes of stroke and of hospitalization for heart failure (≥80 mmHg) and myocardial infarction (≥90 mmHg). A lower achieved DBP (<70 mmHg) was associated with a higher risk for the primary outcome [hazard ratio (HR) 1.29, 95% confidence interval (95% CI) 1.15–1.45; P < 0.0001], myocardial infarction HR 1.54 (95% CI 1.26–1.88, P < 0.0001) and hospitalization for heart failure HR 1.81 (95% CI 1.47–2.24, P < 0.0001) and all-cause death (HR 1.19, 95% CI 1.04–1.35; P < 0.0001) while there was no signal for stroke and CV death compared to DBP 70 to <80 mmHg. A decrease of DBP was associated with lower risk when baseline DBP was >80 mmHg. The associations to outcomes were similar when patients were divided to SBP 120 to <130 mmHg or 130 to <140 mmHg for DBP or PP.ConclusionCompared to a DBP of 70 to <80 mmHg, lower and higher DBP was associated with a higher risk in patients achieving a SBP of 120 to <140 mmHg. Associations of DBP and PP to risk were similar notably at controlled SBP. These data suggest at optimal achieved SBP, risk is still defined by low or high DBP. These findings support guidelines which take DBP at optimal SBP control into consideration.
European Heart Journal – Oxford University Press
Published: Jun 4, 2018
Keywords: Hypertension; Cardiovascular risk; Stroke; Myocardial infarction; Heart failure; Blood pressure; Diastolic blood pressure; ONTARGET; TRANSCEND
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.